| Type 1 DM | Type 2 DM | MODY | Neonatal DM | CFRD | Genetic syndromes | MIDD |
---|---|---|---|---|---|---|---|
Patients, n (%) | 206 (74.6) | 49 (17.8) | 8 (2.9) | 2 (0.7) | 2 (0.7) | 6 (2.2) | 3 (1.1) |
Age at diagnosis, years | 9.9 ± 3.8 | 13.7 ± 2.1 | 13.5 ± 2.8 | 0.1 | 10.6 | 2.1 ± 2.7 | 4.1 ± 0.9 |
BMI Z-score | −0.83 ± 1.22 | 2.59 ± 1.47 | − 0.33 ± 1.00 | NA | 0.45 ± 4.01 | NA | − 3.29 ± 2.05 |
HbA1c, % | 12.1 ± 2.5 | 10.0 ± 2.0 | 9.7 ± 3.0 | NA | 6.9 | 9.4 ± 2.9 | 8.2 ± 2.8 |
C-peptide, ng/mL | 0.9 ± 1.0 | 4.7 ± 2.7 | 2.2 ± 1.9 | 0.45 | 3.1 | 22.9 ± 38.8 | 6.3 ± 4.9 |
Antibody positivity, n (%) | 137/190 (72.1) | 7/49 (14.3) | 0 | 0 | 0 | 0 | 0 |
DKA at diagnosis, n (%) | 40 (19.4) | 1 (2.0) | 0 | 0 | 0 | 0 | 0 |